Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.05. | Filament Health Announces Transition From Otcqb To Otc Pink Limited | 3 | CNW | ||
22.05. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2025 | 489 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2025.ISIN NameCA31685W1068 FILAMENT... ► Artikel lesen | |
FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
22.05. | XFRA 7QS: AUSSETZUNG/SUSPENSION | 180 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH... ► Artikel lesen | |
20.05. | Filament Health Corp: Filament shares to delist from Cboe Canada May 21 | 1 | Stockwatch | ||
19.05. | Filament Health Corp.: Filament Health Announces Voluntary Delisting From Cboe Canada | 91 | PR Newswire | VANCOUVER, BC, May 19, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
09.05. | Filament Health reports Q1 results | 1 | Seeking Alpha | ||
09.05. | Filament Health Corp.: Filament Health Announces First Quarter 2025 Financial Results And Operational Highlights | 31 | PR Newswire | VANCOUVER, BC, May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
09.04. | Filament Health Corp: Filament receives U.S. FDA OK for PEX010 study | 1 | Stockwatch | ||
09.04. | Filament Health Announces Fda Authorization Of Phase 2 Clinical Trial Studying Pex010, The Company's Botanical Psilocybin Drug Candidate, In Opioid Use Disorder | 2 | CNW | ||
04.04. | Filament Health to raise C$0.9M, delist from Cboe Canada | 1 | Seeking Alpha | ||
04.04. | Filament Health Corp: Filament Health arranges $900,000 private placement | 2 | Stockwatch | ||
04.04. | Filament Health Corp.: Filament Health Announces Private Placement And Intention To Voluntarily Delist From Cboe Canada | 120 | PR Newswire | Financing driven by existing investor Negev and Filament's Board of Directors
Company also announces intention to voluntarily delist from Cboe Canada
VANCOUVER... ► Artikel lesen | |
01.04. | Filament Health Corp.: Filament Health Reports Q4 And Year End 2024 Financial Results And Operational Highlights | 76 | PR Newswire | VANCOUVER, BC, April 1, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
01.04. | Filament Health reports FY results | 1 | Seeking Alpha | ||
17.03. | Filament Health Corp: Filament Health talks PEX010 safety data | 1 | Stockwatch | ||
17.03. | Filament Health Corp.: Filament Health Announces Positive Data From Phase 2 Study Of Pex010 In Patients With Alcohol Use Disorder | 64 | PR Newswire | Open-label study at Psychiatric Centre Copenhagen found that alcohol consumption significantly decreased amongst participants dosed with Filament's botanical psilocybin... ► Artikel lesen | |
06.02. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference | 441 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as... ► Artikel lesen | |
22.01. | Filament Health Corp: Filament Health ships PEX010 to UW-Madison | 1 | Stockwatch | ||
21.01. | Filament Health Announces Shipment Of Botanical Psilocybin To The University Of Wisconsin-madison | 1 | CNW | ||
07.01. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum | 448 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 26,430 | +4,38 % | Bayer: Die Käufer geben nicht auf | Die Mitte Mai vorgelegten Quartalszahlen des Bayer-Konzerns waren zwar nicht gut, aber sie fielen besser aus als von den Analysten erwartet. Doch die zunächst positive Reaktion traf auf Verkäufe, am... ► Artikel lesen | |
AURORA CANNABIS | 4,915 | +0,72 % | Stocks in Play: Aurora Cannabis Inc. | ||
CANOPY GROWTH | 1,198 | +6,02 % | Nach zuletzt starken Gewinnen: Erwartung verfehlt: Crasht jetzt die Aktie von Canopy Growth? | © Foto: Dall-EDer kanadische Cannabiskonzern Canopy Growth hat mit seinen am Freitagmittag vorgelegten Quartalszahlen die Erwartungen der Analysten nicht erfüllen können.In den vergangenen Wochen ist... ► Artikel lesen | |
TILRAY BRANDS | 0,358 | -0,69 % | Tilray Brands, Inc.: Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer | ||
INNOCAN PHARMA | 0,111 | +6,25 % | Breaking News: Innocan Q1-25 Zahlen! Mit Wachstum ins neue Jahr! | ||
CRONOS GROUP | 1,704 | +0,47 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
SYNBIOTIC | 3,095 | -1,75 % | EQS-DD: SYNBIOTIC SE: HempConsult GmbH, Verleih (unentgeltlich) von 50.000 Aktien im Rahmen einer Wertpapierleihe. | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
23.04.2025 / 09:22... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 4,546 | -0,61 % | Green Thumb Industries Inc: Green Thumb to hold cannabis, music festival | ||
CHRISTINA LAKE CANNABIS | 0,021 | 0,00 % | Cenovus shuts in Christina Lake oil sands production due to wildfires | ||
AXSOME THERAPEUTICS | 93,78 | -1,06 % | Axsome Therapeutics auf der 45. jährlichen William Blair Growth Stock Konferenz: Strategische Einblicke | ||
JAGUAR HEALTH | 4,000 | +1,52 % | Jaguar Health, Inc.: Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into definitive agreements for the purchase and... ► Artikel lesen | |
JAZZ PHARMACEUTICALS | 95,92 | 0,00 % | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ... | Phase 2 trial results continue to show clinically meaningful efficacy and durable responses, including 36.5-month median overall survival after four years of follow-up... ► Artikel lesen | |
TRULIEVE CANNABIS | 3,576 | +3,47 % | Trulieve Launches "Roll-Up for Justice" Campaign to Support Mission [Green] | ||
CORBUS PHARMACEUTICALS | 7,300 | -1,35 % | Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity | CB1 inverse agonism is a clinically validated mechanism to induce weight loss CRB-913 is markedly more peripherally restricted compared to monlunabant and rimonabantSAD/MAD Phase 1 trial scheduled... ► Artikel lesen | |
CANNOVUM CANNABIS | 0,225 | 0,00 % | EQS-News: Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich | EQS-News: Cannovum Cannabis AG
/ Schlagwort(e): Strategische Unternehmensentscheidung/Sonstiges
Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich... ► Artikel lesen |